Biocon Consolidated Net Profit Declines 63.45% In The March 2026 Quarter

08-May-26   08:59 Hrs IST
Net profit of Biocon declined 63.45% to Rs 125.90 crore in the quarter ended March 2026 as against Rs 344.50 crore during the previous quarter ended March 2025. Sales rose 2.90% to Rs 4484.30 crore in the quarter ended March 2026 as against Rs 4358.10 crore during the previous quarter ended March 2025.

For the full year,net profit declined 61.95% to Rs 385.60 crore in the year ended March 2026 as against Rs 1013.30 crore during the previous year ended March 2025. Sales rose 11.48% to Rs 16779.90 crore in the year ended March 2026 as against Rs 15052.20 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4484.304358.10 3 16779.9015052.20 11
OPM %22.7524.74 -20.5921.04 -
PBDT841.30902.70 -7 2807.503477.10 -19
PBT327.90466.40 -30 850.801790.10 -52
NP125.90344.50 -63 385.601013.30 -62

Powered by Capital Market - Live News

Invest with clarity

on Chola Securities Mobile & Web App.

Stay organised, informed & in control while accessing your portfolio, reports, trading tools and service requests—all in one seamless platform.

Download the app now → The new app is listed as Chola Securities- Prime Access on App store & Google Play.
Also available on Web, Click to explore
Trading App Screen
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web